COPD: current therapeutic interventions and future approaches

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Respiratory Journal

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.05.00139104PMID 15929966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD: A Pilot Study

  2006cited by this paper
• Treatment of pulmonary arterial hypertension.

  2006cited by this paper
• Endothelin receptor antagonists for pulmonary arterial hypertension.

  2005cited by this paper
• Erratum: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis (Clinical Infectious Diseases (July 15, 2004) 39 (206-217))

  2005cited by this paper
• Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

  2004cited by this paper
• Treatment of pulmonary arterial hypertension.

  2004cited by this paper
• Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.

  2004cited by this paper
• Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice.

  2004cited by this paper
• PDE4 inhibitors in COPD F a more selective approach to treatment

  2004cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2004cited by this paper
• Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

  2004cited by this paper
• Early results of endoscopic lung volume reduction for emphysema.

  2004cited by this paper
• Mechanisms of pulmonary fibrosis.

  2004cited by this paper
• Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.

  2004cited by this paper
• Effect of low‐dose theophylline on airway inflammation in COPD

  2004cited by this paper
• Inhibition of IL-6 for the treatment of inflammatory diseases.

  2004cited by this paper
• Mediators of Chronic Obstructive Pulmonary Disease

  2004cited by this paper
• Recent advances in the design of matrix metalloprotease inhibitors.

  2004cited by this paper
• α1-Antitrypsin deficiency · 6: New and emerging treatments for α1-antitrypsin deficiency

  2004cited by this paper
• Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease

  2004cited by this paper
• Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.

  2004cited by this paper
• Treatment of stable chronic obstructive pulmonary disease.

  2004cited by this paper
• Discovery of BRL 50481, a Selective Inhibitor of Phosphodiesterase 7: In vitro Studies in Human Monocytes, Lung Macrophages and CD8 + T-Lymphocytes

  2004cited by this paper
• Advances in pharmacotherapy for tobacco dependence.

  2004cited by this paper
• The role of long-acting bronchodilators in the management of stable COPD.

  2004cited by this paper
• Potential therapeutic effect of antioxidant therapy in shock and inflammation.

  2004cited by this paper
• Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

  2004cited by this paper
• Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro

  2004cited by this paper
• The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

  2004cited by this paper
• COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2004cited by this paper
• A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease

  2004cited by this paper
• Small airways in COPD.

  2004cited by this paper
• Current pharmacological treatments for nicotine dependence.

  2004cited by this paper
• Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance

  2004cited by this paper
• Alveolar Macrophages as Orchestrators of COPD

  2004cited by this paper
• The pulmonary and extra‐pulmonary effects of high‐dose formoterol in COPD: A comparison with salbutamol

  2004cited by this paper
• Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease.

  2004cited by this paper
• Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.

  2004cited by this paper
• The Structure of H-2Kb and Kbm8 Complexed to a Herpes Simplex Virus Determinant: Evidence for a Conformational Switch That Governs T Cell Repertoire Selection and Viral Resistance12

  2004cited by this paper
• Oxygen sensing by HIF hydroxylases

  2004cited by this paper
• Molecular Mechanisms of Anti-Inflammatory Action of Erythromycin in Human Bronchial Epithelial Cells: Possible Role in the Signaling Pathway That Regulates Nuclear Factor-κB Activation

  2004cited by this paper
• Tiotropium bromide

  2004cited by this paper
• Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn.

  2004cited by this paper
• Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

  2004cited by this paper
• The nature of small-airway obstruction in chronic obstructive pulmonary disease.

  2004cited by this paper
• Prospects for new drugs for chronic obstructive pulmonary disease.

  2004cited by this paper
• T-cell trafficking in asthma: lipid mediators grease the way

  2004cited by this paper
• Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.

  2004cited by this paper
• [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

  2004cited by this paper
• Bupropion and other non-nicotine pharmacotherapies

  2004cited by this paper
• NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

  2004cited by this paper
• An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema

  2004cited by this paper
• The effects of macrolides on inflammatory cells.

  2004cited by this paper
• Talniflumate (Genaera).

  2004cited by this paper
• Respiratory Research BioMed Central Review Stem cells and repair of lung injuries

  2004cited by this paper
• The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.

  2004cited by this paper
• Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes

  2004cited by this paper
• Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2

  2004cited by this paper
• Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD

  2004cited by this paper
• The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review.

  2004cited by this paper
• Clinical proteomics in lung diseases.

  2004cited by this paper
• Techniques to assess in-vivo tissue metabolism directly in humans without biopsy samples.

  2004cited by this paper
• Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages

  2004cited by this paper
• Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.

  2004cited by this paper
• alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

  2004cited by this paper
• Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.

  2004cited by this paper
• Endothelin receptor antagonists in pulmonary arterial hypertension.

  2004cited by this paper
• Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo

  2003cited by this paper
• Novel IKK inhibitors: beta-carbolines.

  2003cited by this paper
• Vaccines against drugs of abuse: a viable treatment option?

  2003cited by this paper
• Bronchoscopic volume reduction with valve implants in patients with severe emphysema.

  2003cited by this paper
• Inhibitory effects of interferon-gamma on the heterologous desensitization of beta-adrenoceptors by transforming growth factor-beta 1 in tracheal smooth muscle.

  2003cited by this paper
• The lymphocytic cholinergic system and its biological function.

  2003cited by this paper
• Chemokines and their receptors in asthma and chronic obstructive pulmonary disease

  2003cited by this paper
• Pulmonary hypertension in chronic obstructive pulmonary disease

  2003cited by this paper
• Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1

  2003cited by this paper
• The non-neuronal cholinergic system in humans: expression, function and pathophysiology.

  2003cited by this paper
• Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

  2003cited by this paper
• Tolerance to bronchodilating effects of salmeterol in COPD.

  2003cited by this paper
• Theophylline: new perspectives for an old drug.

  2003cited by this paper
• Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells.

  2003cited by this paper
• Catabolic/anabolic balance and muscle wasting in patients with COPD.

  2003cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I

  2003cited by this paper
• Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease

  2003cited by this paper
• A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD.

  2003cited by this paper
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

  2003cited by this paper
• Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

  2003cited by this paper
• Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension

  2003cited by this paper
• Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD

  2003cited by this paper
• Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• PDE4D plays a critical role in the control of airway smooth muscle contraction

  2003cited by this paper
• Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipram

  2003cited by this paper
• Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

  2003cited by this paper
• The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?

  2003cited by this paper
• SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

  2003cited by this paper
• Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations.

  2003cited by this paper
• Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

  2003cited by this paper
• Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease

  2003cited by this paper
• Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

  2003cited by this paper
• In Vivo Efficacy in Airway Disease Models of N-(3,5-Dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), a Selective Phosphodiesterase 4 Inhibitor for Inhaled Administration

  2003cited by this paper

• Proteomic profiling of bronchoalveolar lavage following human segmental endotoxin challenge—a potential exacerbation model

  2026cites this paper
• Phosphodiesterase-4 Inhibitors in COPD Therapy: A Review of Mechanisms, Limitations, and Emerging Opportunities

  2025cites this paper
• Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions

  2025cites this paper
• Novel NLRP3 inhibitors mitigate acute radiation-induced lung injury by suppressing pyroptosis in alveolar epithelial cells.

  2025cites this paper
• Crosstalk between airway epithelial cells and mast cells in airway inflammation

  2025cites this paper
• Effect of allyl isothiocyanate on 4-HNE induced glucocorticoid resistance in COPD and the underlying mechanism

  2024cites this paper
• A Causal Network-Based Markov Decision Process Model for Intervention Planning

  2024cites this paper
• Simplifying pharmacotherapy for patients with COPD: a viewpoint

  2023cites this paper
• Terpenoids as Human Neutrophil Elastase (HNE) Inhibitors: A Comprehensive Review of Natural Anti‐inflammatory Isoprenoids

  2023cites this paper
• The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics

  2023cites this paper
• Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma–COPD Overlap (ACO) Model

  2023cites this paper
• Research on evolution process of full‐layer incision of skin tissue under different laser incidences

  2023cites this paper
• Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease

  2023cites this paper
• A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention

  2023cites this paper
• Profiling alveolar macrophage responses to inhaled compounds using in vitro high content image analysis.

  2023cites this paper
• Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial.

  2022cites this paper
• Exacerbation of Elastase-Induced Emphysema via Increased Oxidative Stress in Metallothionein-Knockout Mice

  2022cites this paper
• miR449 Protects Airway Regeneration by Controlling AURKA/HDAC6-Mediated Ciliary Disassembly

  2022cites this paper
• Natural products in the treatment of pulmonary emphysema: Therapeutic effects and mechanisms of action.

  2022cites this paper
• On the ameliorative potential of Baccharis trimera in an experimental model of pulmonary disease

  2022cites this paper
• Blood-Based Transcriptomic and Proteomic Biomarkers of Radiologic Emphysema

  2022cites this paper
• Aerobic exercise training engages cholinergic signaling to improve emphysema induced by cigarette smoke exposure in mice.

  2022cites this paper
• Artemisia lactiflora Extracts Prevent Inflammatory Responses of Human Macrophages Stimulated with Charcoal Pyrolysis Smoke

  2021cites this paper
• The Aryl Hydrocarbon Receptor Attenuates Acute Cigarette Smoke-Induced Airway Neutrophilia Independent of the Dioxin Response Element

  2021cites this paper
• Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.

  2021cites this paper
• Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

  2021cites this paper
• Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms

  2021cites this paper
• Editorial: Innovative In Vitro Models for Pulmonary Physiology and Drug Delivery in Health and Disease

  2021cites this paper
• Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE

  2021cites this paper
• Characterization of an elastase-induced emphysema model in immune-deficient rats.

  2020cites this paper
• The role of Siglec-F as a regulator of alveolar macrophage function and adaptation

  2020cites this paper
• Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation

  2020cites this paper
• Solanum nigrum Linne improves DNCB-induced atopic dermatitis-like skin disease in BALB/c mice

  2020influential citation
• The Natural Polypeptides as Significant Elastase Inhibitors

  2020cites this paper
• Retracted: Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling

  2019cites this paper
• Enfermedad pulmonar obstructiva crónica (EPOC)

  2019cites this paper
• A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications

  2019cites this paper
• Extracellular Matrix Component Remodeling in Respiratory Diseases: What Has Been Found in Clinical and Experimental Studies?

  2019cites this paper
• Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.

  2019cites this paper
• Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity

  2019cites this paper
• Human neutrophil elastase (HNE) inhibitory polyprenylated acylphloroglucinols from the flowers of Hypericum ascyron.

  2019cites this paper
• Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases

  2019cites this paper
• 12 – Asthma and chronic obstructive pulmonary disease

  2018cites this paper
• Particle interactions in complex dry powder inhaled formulations and single particle aerosol mass spectrometry

  2018cites this paper
• Effects of different physical therapy programs on perceived health status in acute exacerbation of chronic obstructive pulmonary disease patients: a randomized clinical trial

  2018cites this paper
• Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity

  2018cites this paper
• Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors

  2018cites this paper
• Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteins

  2018cites this paper
• Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in Mice

  2017cites this paper
• Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD

  2017cites this paper
• Next generation of anti-inflammatory therapy for COPD?

  2017cites this paper
• A Plant Proteinase Inhibitor from Enterolobium contortisiliquum Attenuates Pulmonary Mechanics, Inflammation and Remodeling Induced by Elastase in Mice

  2017cites this paper
• Systems pharmacology-based dissection of the active ingredients and targets of Yiqi Zishen formula for application to COPD

  2017cites this paper
• SALVIANOLIC ACID B FOR PULMONARY DELIVERY TOWARDS REVERSAL OF EMPHYSEMA

  2017cites this paper
• Effects of Sodium Houttuyfonate on Pulmonary Inflammation in COPD Model Rats

  2017cites this paper
• Identification of novel therapeutics for chronic obstructive pulmonary disease

  2017cites this paper
• Sulfated dehydropolymer of caffeic acid: In vitro anti-lung cell death activity and in vivo intervention in emphysema induced by VEGF receptor blockade.

  2017cites this paper
• Drugs Affecting TRP Channels.

  2017cites this paper
• 4 Special Consideration in Treating Patients of Overlap Between Asthma and COPD

  2017cites this paper
• Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations

  2017cites this paper
• Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines

  2017cites this paper
• The Plant-Derived Bauhinia bauhinioides Kallikrein Proteinase Inhibitor (rBbKI) Attenuates Elastase-Induced Emphysema in Mice

  2016cites this paper
• TAK-242 attenuates acute cigarette smoke-induced pulmonary inflammation in mouse via the TLR4/NF-κB signaling pathway.

  2016cites this paper
• The role of A-kinase anchoring proteins (AKAPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD)

  2016cites this paper
• Airway Epithelial Cell Cilia and Obstructive Lung Disease

  2016cites this paper
• Inhalation and Nasal Formulations

  2016cites this paper
• Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD

  2016cites this paper
• Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases.

  2016cites this paper
• IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease

  2015influential citation
• Devices for Dry Powder Drug Delivery to the Lung

  2015influential citation
• systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD

  2015cites this paper
• Causation of cigarette smoke-induced emphysema by p-benzoquinone and its prevention by vitamin C.

  2015cites this paper
• Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD

  2015cites this paper
• Biological targets and mechanisms of action of natural products from marine cyanobacteria.

  2015cites this paper
• Combination of Fluticasone Furoate and Vilanterol for the Treatment of Chronic Obstructive Pulmonary Disease

  2014influential citation
• Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.

  2014cites this paper
• Sulfated Caffeic Acid Dehydropolymer Attenuates Elastase and Cigarette Smoke Extract–induced Emphysema in Rats: Sustained Activity and a Need of Pulmonary Delivery

  2014cites this paper
• 호흡기 질환 연관 유전자 특이적 siRNA, 그러한 siRNA를 포함하는 이중나선 올리고 RNA 구조체 및 이를 포함하는 호흡기 질환 예방 또는 치료용 조성물

  2014cites this paper
• SiRNA-based therapies for pulmonary diseases.

  2014cites this paper
• Chronic Obstructive Pulmonary Disease (COPD)

  2014influential citation
• Prevalence and Therapy of Chronic Obstructive Pulmonary Disease in Karachi

  2014cites this paper
• Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial

  2014influential citation
• Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease

  2014cites this paper
• Eosinophils in the Lung – Modulating Apoptosis and Efferocytosis in Airway Inflammation

  2014cites this paper
• Cytokine inhibition in the treatment of COPD

  2014cites this paper
• Mechanisms of Cigarette Smoke-Induced Inflammation and the Exacerbated Response to Bacteria in Mice

  2014cites this paper
• Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling

  2013cites this paper
• Prevalence and Therapy of Chronic Obstructive Disease in Karachi

  2013cites this paper
• Chapter 75 – Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease

  2013cites this paper
• Role of Proteases in Inflammatory Lung Diseases

  2013cites this paper
• RNAi Therapeutic Platforms for Lung Diseases

  2013cites this paper
• Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.

  2013cites this paper
• Iconographies supplémentaires de l'article : Beneficial effects of aminoguanidine against streptozotocin-induced pathological changes in diabetic mice kidney

  2013cites this paper
• Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase

  2013cites this paper
• Cigarette Smoke Suppresses the Surface Expression of c-kit and FcεRI on Mast Cells

  2013cites this paper
• CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARIES Back to the Future: Inhaled Drug Products

  2013cites this paper
• Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.

  2013cites this paper
• Back to the future: inhaled drug products.

  2013cites this paper
• Elastase-2/Leukocyte Elastase

  2013cites this paper